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Abstract
A significant number of dietary restrictions are imposed traditionally and uniformly on 
maintenance dialysis patients, whereas there is very little data to support their benefits. Recent 
studies indicate that dietary restrictions of phosphorus may lead to worse survival and poorer 
nutritional status. Restricting dietary potassium may deprive dialysis patients of heart-healthy diets 
and lead to intake of more atherogenic diets. There is little data about the survival benefits of 
dietary sodium restriction, and limiting fluid intake may inherently lead to lower protein and 
calorie consumption, when in fact dialysis patients often need higher protein intake to prevent and 
correct protein-energy wasting. Restricting dietary carbohydrates in diabetic dialysis patients may 
not be beneficial in those with burnt-out diabetes. Dietary fat including omega-3 fatty acids may 
be important caloric sources and should not be restricted. Data to justify other dietary restrictions 
related to calcium, vitamins and trace elements are scarce and often contradictory. The restriction 
of eating during hemodialysis treatment is likely another incorrect practice that may worsen 
hemodialysis induced hypoglycemia and nutritional derangements. We suggest careful relaxation 
of most dietary restrictions and adoption of a more balanced and individualized approach, thereby 
easing some of these overzealous restrictions that have not been proven to offer major advantages 
to patients and their outcomes and which may in fact worsen patients’ quality of life and 
satisfaction. This manuscript critically reviews the current paradigms and practices of 
recommended dietary regimens in dialysis patients including those related to dietary protein, 
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carbohydrate, fat, phosphorus, potassium, sodium, and calcium, and discusses the feasibility and 
implications of adherence to ardent dietary restrictions.
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Dietary counseling and nutritional interventions are quintessential components in the 
management of chronic kidney disease (CKD) patients, including those who receive 
maintenance dialysis therapy. To that end, in the United States it is a regulatory requirement 
for an outpatient dialysis clinic to have an on-site registered dietitian to provide dietary 
monitoring and counseling to all dialysis patients.1 Both dietitians and nephrologists often 
impose a number of dietary restrictions on their patients related to dietary phosphorus, 
potassium, sodium, fluid intake, and macronutrients including carbohydrate and fat. 
Dietitians also emphasize the importance of high dietary protein intake in dialysis patients, 
while they may also recommend weight loss efforts in patients with morbid obesity who are 
not yet eligible for kidney transplant wait-listing.2 Eating or not eating during hemodialysis 
treatment is another controversy; in the United States many dialysis centers prohibit food 
intake during dialysis treatment, while in other countries meals are proactively served to 
dialysis patients.3
Many of these dietary recommendations for dialysis patients are highly restrictive (see Table 
1), and the task of finding anything permissible to eat is a major challenge for dialysis 
patients. Indeed, many of these dietary restrictions such as a low potassium diet contradict 
the current recommendations for a heart-healthy diet.4 It is not an exaggeration to say that 
the dialysis dietary regimen is among the most restrictive diets, and these restrictions may 
render many patients frustrated and lead to suboptimal adherence and compliance. In this 
manuscript some of these dietary recommendations and restrictions are critically reviewed 
and their impact on dialysis patient outcomes and recommendations for future research 
discussed.
Dietary Protein Recommendations
Non-dialysis dependent (NDD) CKD patients are generally advised to eat lower amounts of 
protein. The so-called low protein diet (LPD) that is often recommended for non-diabetic, 
NDD-CKD Stages 3b, 4 and 5 (eGFR<45 ml/min/1.73 m2 BSA) targets a daily dietary 
protein intake of ~0.6 g/kg/day, i.e., 35 to 45 g of total daily protein for a 60 to 70 kg 
person.5 The LPD is significantly lower than what the non-vegetarian general population in 
the USA and most Western countries eat, i.e., 0.9 to 1.1 g/kg/day. Furthermore, the Institute 
of Medicine “Food and Nutrition Board” recommends a daily dietary protein intake of 0.8 
g/kg/day in the general population, which is 0.2 g/kg/d above the minimum dietary protein 
requirement, offering a safety cushion against protein-energy malnutrition.5, 6 The so-called 
very low protein diet (vLDP) consists of only 0.3 g/kg/day and is also recommended for 
very late stage NDD-CKD; it invariably needs to be supplemented by either essential amino 
acids or their keto-analogues.5, 7
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Notwithstanding the ongoing discussion about the safety, adequacy and effectiveness of the 
LPD or supplemented vLPD for NDD-CKD patients, for those who transition to dialysis 
treatment the guidelines are relatively consistent in that the recommended dietary protein 
intake range is to be 1.2 to 1.4 g/kg/day, which is 2-times higher than the LPD and even 
higher than what the general population eats. This poses a major challenge for the successful 
transition from NDD-CKD to dialysis therapy, especially since many of these patients, who 
were used to LPD, need to undergo significant re-education and acculturation. In reality, 
over half of dialysis patients have inadequate dietary protein [<1.0 g/kg/day as measured by 
the normalized protein nitrogen appearance (nPNA) also known as normalized protein 
catabolic rate (nPCR)] as shown in a recent study by Shinaberger at al,8 (Figure 1). The 
estimates of nPNA or nPCR are calculated by urea kinetic modeling.8–10 As to whether such 
a high protein intake of 1.2–1.4 g/kg/day is useful or not, observational studies including 
those by Kalantar-Zadeh et al.,9 Shinaberger et al.,8 and Ravel et al.,10 have suggested 
superior hospitalization and survival outcomes, although there has never been any controlled 
trial to corroborate these dietary targets. According to Shinaberger et al.,8 the best survival 
in 53,933 hemodialysis patients was achieved when the nPCR was in the 1.2–1.4 g/kg/day 
range (Figure 2).
A high protein intake of ~1.2 g/kg/day poses additional challenges including a somewhat 
high dietary phosphorus and potassium load, higher risk of metabolic acidosis, and higher 
probability of increased fluid intake by virtue of the need for larger food volume (Figure 
3).11 Nevertheless, since the advantages of higher dietary protein intake may outweigh its 
potential challenges in thrice-weekly hemodialysis patients, they should be consistently 
reminded and educated during rounds to increase their dietary protein intake including 
consumption of more meat, fish, eggs and poultry as well as fruits and vegetable high in 
protein such as legumes and tofu based foods. If such interventions are inadequate, then 
meals during dialysis should be provided with high protein content3 and high protein oral 
nutritional supplements should be offered.6 Meals and supplements during hemodialysis 
treatment is a separate topic and beyond the scope of this review article.3, 6
Dietary Phosphorus Restrictions
Counseling on dietary phosphorus and monitoring patients’ phosphorus intake are perhaps 
the most time-consuming tasks of dialysis clinic dietitians in the United States and many 
other countries.12, 13 Nevertheless, recent data examining the impact of dietary phosphorus 
counseling efforts on dialysis patient outcomes have questioned the wisdom of this several 
decade-old paradigm, supported by the notion that restricting dietary protein intake via 
traditional approaches can invariably lead to lower dietary protein intake and hence may 
increase the risk of protein-energy wasting and death.14 In a recent study by Lynch et al.,15 
the impact of prescribed dietary phosphorus restrictions on long-term survival was examined 
in 1,751 hemodialysis patients using marginal structural models to adjust for longitudinal 
confounding. The study found that more restrictive prescribed dietary phosphorus was 
associated with poorer indices of nutritional status and that there was an incrementally 
greater survival with more liberal dietary phosphorus prescription; in particular, those who 
were prescribed >1000 mg/day dietary phosphorus or no dietary restriction had 27% and 
29% greater survival, respectively.15
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In another study, Shinaberger et al.14 reported on 30,075 prevalent hemodialysis patients in 
the USA; in comparison to patients whose serum phosphorus and dietary protein intake both 
rose over 6 months, those whose serum phosphorus decreased but whose protein intake 
increased had 10% greater survival, whereas those whose phosphorus increased but whose 
dietary protein decreased or those whose phosphorus and dietary protein intake 
concomitantly decreased had 11% and 6% worse mortality, respectively.14
Both old and new data have been relatively consistent in showing that a low serum 
phosphorus level, e.g. <3.5 mg/dL, is associated with higher mortality independent of age16 
and other confounders.17 To that end, adherence to KDIGO’s guidelines of “normalization” 
of serum phosphorus, which may mean targeting levels even below 3.5 mg/dL in dialysis 
patients, is a challenging dilemma.18 Hence, prescribed dietary phosphorus restriction may 
not be associated with improved survival among hemodialysis patients if it results in 
inadequate protein intake, and heightened dietary phosphorus restrictions may be associated 
with greater mortality, such that the risk of controlling serum phosphorus by restricting 
dietary protein intake may outweigh the benefits and lead to greater mortality in dialysis 
patients.14, 15
It is important to note, however, that in a study using Food Frequency Questionnaires in a 
cohort of 224 hemodialysis patients over 5 years., Noori et al.19 showed that higher dietary 
phosphorus intake and higher dietary phosphorus to protein (P-to-P) ratios were each 
associated with increased death risk even after adjustments for serum phosphorus, 
phosphorus binders and their classes, dietary protein, energy, and potassium intake (Figure 
4). In this study, dietary P-to-P ratios of 14 to <16, and ≥16 mg/g were associated with 80% 
and 99% higher death risk, respectively, compared to those who ate food with a P-to-P ratio 
of <14 mg/g.19 Hence, the choice of type of protein that has lower P-to-P ratio such as egg 
whites may have a bearing on survival.13
Do recent studies suggest that we should abandon any type of dietary phosphorus restriction 
in dialysis patients? There is little doubt that hyperphosphatemia is associated with poorer 
outcomes in CKD.20 The aforementioned studies offer important opportunities to re-channel 
dietary counseling efforts into the correct direction with greater focus on understanding and 
identifying the sources of added phosphorus in processed foods21 and better appreciating 
that natural (organic) phosphorus is not well absorbed, e.g. approximately 40–60% of 
phosphorus from animal protein and <40% of plant-based protein is usually absorbed 
through the GI tract, whereas the added or inorganic phosphorus is almost 100% 
absorbable.17, 21, 22 Hence, the incorrect practice of frightening dialysis patients in order to 
avoid natural sources of protein that may also have high phosphorus content (such as meat, 
poultry, fish, eggs, natural dairy products, and legumes) should be discouraged.
We believe that dietitians should spend more time and effort on educating dialysis patients 
on how to: (1) identify added phosphorus in processed foods in order to avoid them,23 (2) 
choose natural sources of proteins with the lowest phosphorus-to-protein ratio such as egg 
whites;24 and (3) take phosphorus binders correctly and diligently, including avoidance of 
consuming binders on an empty stomach (e.g. before meals), and adjustment of binder dose 
based on the binder potency and in particular based on the estimated amount of phosphorus 
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in each meal.12 To give blind phosphorus binder prescriptions to dialysis patients with a 
fixed number of pills “per meal” without providing first such fundamental education about 
types of dietary phosphorus or without educating the proper use of phosphorus binders is 
indeed an incorrect approach adopted by many professional caring for dialysis patients and 
should be reexamined.12 Additional studies including randomized controlled trials should 
examine whether non-dietary control of phosphorus or restriction of non-protein sources of 
phosphorus is safe and more effective, keeping in mind that hyperphosphatemia is not 
merely a reflection of dietary phosphorus intake but of also many other factors including 
hyperparathyroidism.25, 26
Dietary Potassium Restrictions
Dietary potassium restrictions are often implemented during earlier stages of CKD when 
patients are still non-dialysis dependent, and are reinforced in the majority of patients 
transitioning to ESRD, particularly in hemodialysis patients. A recent cohort study over 3 
years in 81,013 prevalent hemodialysis patients suggested that the best pre-hemodialysis 
serum potassium range associated with the greatest survival was 4.6 to 5.3 mEq/L, whereas 
potassium levels <4.0 or ≥5.6 mEq/L were associated with increased mortality.27 Another 
clinically relevant finding in this study was that serum potassium correlated closely with 
nutritional markers, in particular nPCR (nPNA) suggesting that patients who eat more 
protein also tend to have higher serum potassium level (Figure 5).27 In a more recent cohort 
study that examined the mortality of hyperkalemia in 111,651 hemodialysis and 10,468 
peritoneal dialysis patients, the latter group was 3.3 times more likely to have lower serum 
potassium <4.0 mEq/L, and their death risk was 51% and 52% higher with serum potassium 
levels <3.5 mEq/L and ≥5.5 mEq/L.28 Hence, both hypo- and hyperkalemia appear to be 
harmful in dialysis patients irrespective of dialysis modality. It is important to note that the 
variability of serum potassium in dialysis patients is not the exclusive function of dietary 
potassium load and that several other factors such as potassium concentration in the 
dialysate bath or the dialysis treatment length and frequency play important roles.
A recent study by Noori et al.29 examined the association between dietary potassium intake 
via Food Frequency Questionnaire30 at the start of a 5-year cohort of 224 hemodialysis 
patients in Southern California and found that patients with higher potassium intake had 
greater dietary energy, protein, and phosphorus intake and higher pre-dialysis serum 
potassium and phosphorus levels. Greater dietary potassium intake was associated with 
increased mortality in survival models that were adjusted for nutritional factors including 
serum potassium and phosphorus levels, in that death risk of the 3 higher quartiles of dietary 
potassium intake were 1.4, 2.2 and 2.4 times higher than the lowest dietary potassium 
quartile.29 Hence, higher dietary potassium load per se, independent of serum potassium, is 
incrementally associated with higher mortality.
These and other data have been used to justify strict dietary potassium restrictions in CKD 
and dialysis patients. However, it is important to appreciate that many potassium rich foods 
are considered “heart healthy” including fresh fruits and vegetables, fresh squeezed juices, 
legumes, and grains. 29 Hence, a low potassium diet falls outside of what is generally 
recommended as a healthy diet and life style, and such dietary restrictions may contribute to 
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the burden of cardiovascular disease in the CKD patient population according to several 
studies.4, 31 We suggest educating patients regarding the different sources of potassium and 
empowering our patients to make choices which fall within the “heart healthy” category and 
avoid other sources of potassium so that they obtain the most benefit from a diet with 
moderate amounts of potassium. Hence in this case a relaxation of dietary potassium 
restriction and a more balanced and realistic approach to such overzealous restrictions would 
mean choosing the most beneficial sources of potassium which is only possible through a 
concerted education effort. The use of potassium binding resins for hyperkalemia control 
may also allow for more consumption of heart-healthy diets with less risk of hyperkalemia, 
although their intake can be limited by side effects and more studies are needed.32 Newer 
resins, in development, may facilitate this approach.
Dietary Glycemic Restrictions and Carbohydrate Load
In the United States almost half of all new dialysis patients are diabetic, and many of them 
are automatically continued on the same dietary restrictions as non-CKD patients with 
diabetes.33 Even though high glycemic burden is associated with poor outcomes in the 
dialysis population,34–36 many diabetic dialysis patients develop a so-called “burnt-out 
diabetes” phenomenon, such that their insulin and oral hypoglycemic agents can be 
significantly decreased and at times need to be discontinued due to risk of 
hypoglycemia.37–39 Indeed hemodialysis induced hypoglycemia is an under-recognized and 
widespread event that may happen even more frequently in diabetic dialysis patients.40 
Recent studies suggest that the best hemoglobin A1c target range for diabetic dialysis 
patients is 7 to 9% and that a lower A1c, especially <6% is associated with poor outcomes, 
which may be related to poor nutritional status or other metabolic derangements of 
uremia.34, 37, 41–43 Hence, glycemic restrictions that are traditionally used in non-CKD 
diabetic patients may lead to harm in diabetic dialysis patients. We suggest that dietary 
glycemic restrictions in dialysis patients with A1c <7% be relaxed, and that among patients 
with higher A1c levels careful and balanced dietary recommendations be considered to 
assure the provision of at least 35 Cal/kg/day.6
Dietary Salt and Fluid Restriction
Whereas there are important data suggesting that high interdialytic weight gain is associated 
with higher death risk,44 there are no convincing data to suggest that more dietary sodium 
restriction in dialysis patients has any bearing on outcomes. Indeed recent studies in the 
general population suggest that low salt intake is associated with poorer outcomes.45 With 
regard to fluid restriction, a cohort study by Kalantar-Zadeh et al. in 34,107 hemodialysis 
patients showed that in unadjusted survival analyses, higher weight gain reflecting higher 
fluid intake was associated with better nutritional status including higher protein intake, 
serum albumin, and body mass index and tended to be linked to greater survival.44 The 
higher fluid-gain increments were originally associated with better survival but after 
multivariate adjustment (including for nutritional status) it was associated with higher (not 
lower)death risk. This suggests that the benefit of fluid restriction is achieved only if optimal 
nutritional status and food intake is not compromised.44 While we do not recommend 
complete relaxation of fluid and salt restrictions given the difficulties associated with 
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volume overload, we warn against overzealous salt and fluid restrictions in dialysis patients, 
especially in those with significant residual renal function and urine output, if such dietary 
restrictions would compromise the need for adequate protein and energy intake in these 
patients.
Dietary Fat Restrictions
Although it would seem intuitive to extrapolate the low dietary fat recommendations of the 
general population to dialysis patients, there are virtually no convincing data to suggest that 
restricting dietary fat has any advantage in this latter group. A surprising observation, not 
well known, is that total and LDL hypercholesterolemia, although very common in non-
dialysis ambulatory outpatients, are substantially less prevalent in the dialysis population, 
although the prevalence of hypertriglyceridemia is nearly equivalent.46 In comparative 
analyses of randomly selected hemodialysis patients in Southern California who were one-
to-one randomly matched on gender, race/ethnicity, diabetes mellitus, and age (±5 years) to 
non-dialyzed outpatients from the same geographic area and whose lipid panels were 
measured in the same laboratory center, total cholesterol and LDL and HDL levels were 
−51, −39; −10 mg/dL lower, respectively, in hemodialysis patients than in control subjects 
even after adjustment for body mass index and statin use (p<0.001).46 It is important to note 
that in most epidemiologic studies higher lipoprotein levels47 or higher body fat48 are 
associated with greater survival in dialysis patients, while associations with HDL are more 
complex;49–51 hence, achieving higher circulating levels of lipoproteins and their dietary 
modulation may have favorable impact in dialysis patients.
In a randomized controlled study by Marckmann et al.52 the effects of oral unsaturated fat 
supplements were examined in 40 Danish hemodialysis patients. Fat supplementation 
resulted in increased total energy intake of +380 Cal/day, a 9% greater intake of total energy 
attributed to dietary fat, and a +0.5 kg increase in weight, while serum C-reactive protein fell 
by 1.69 mg/L and there was no significant changes in blood lipids. These investigators 
concluded that dietary unsaturated fat have favorable nutritional benefits.52 The anti-
inflammatory benefits of higher dietary intake of certain fats has recently been shown in a 5-
year cohort of hemodialysis patients, in whom lower dietary omega-6 to omega-3 ratio was 
associated with reduced inflammation over time and a trend toward lower death risk.53 
Hence, it is possible, although not yet proven, that dietary fat not only provides a good 
source of the needed calories, if properly administered it could also have additional benefits 
including dietary modulation of inflammation.54
Dietary Recommendations for Trace Elements and Vitamins
In addition to protein-energy wasting, dialysis patients may also suffer from deficiencies of 
micronutrients, particularly trace elements and vitamins. Common vitamin deficiencies 
observed in maintenance dialysis patients include vitamin C or ascorbic acid, vitamin B6 or 
pyridoxine, folate, and 1,25-dihydroxycholecalciferol or calcitriol, and trace element 
deficiencies may include iron, zinc, and selenium. In contrast, toxicities in dialysis patients 
may include aluminum and possibly copper.55 Examining dietary recommendations for each 
of these vitamins and trace elements is beyond the scope of this review article. However, it 
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is important to note that in dialysis patients there is an abnormally high prevalence of 
antioxidant deficiency which can be engendered or aggravated by low intake of natural 
sources such as fresh fruits and vegetable given the imposed dietary restriction that may be 
associated with inadequate ingestion of antioxidant vitamins such as vitamins E, C, and 
carotenoids.4, 31, 55
Dietary Calcium Restrictions
With the emergence of calcium-free phosphorus binders and recent data on vascular 
calcification,56–58 there has been a drastic change in the prevailing paradigm of maintaining 
positive calcium balance59 and recommending low dietary calcium over the past 10–15 
years.60 Even though virtually all epidemiologic studies show higher death risk associated 
with high serum calcium levels >10.5 mg/dL, low serum calcium levels <8.5 mg/dL are also 
associated with higher mortality.61 A high serum calcium level is not necessarily a result of 
a greater calcium load but may be related to other hormonal derangements including 
hyperparathyroidism.62 The surge in use of calcimimetics63, 64 may complicate the current 
recommendations pertaining to dietary calcium intake in dialysis patients; this is an area that 
begs future research.
In-Center Restrictions for Eating during Hemodialysis
In the United States and Canada there are significant restrictions for eating during 
hemodialysis treatment in dialysis clinics. Among the reasons to justify these restrictions are 
postprandial hypotension, aspiration risk, infection control and hygiene, dialysis staff 
burden, diabetes and phosphorus control, and financial constraints.3 However in other 
countries such as Germany, Japan and many other Europeans and Asians nations, meals and 
meal trays are regularly prepared and served during each hemodialysis treatment session.3 
We believe that in carefully selected and monitored patients, in-center provision of high-
protein meals and/or oral nutritional supplements during hemodialysis is a feasible, 
inexpensive, and patient-friendly strategy.3 Given the fact that meals and supplements 
during hemodialysis would require only a small fraction of the funds currently used for 
dialysis patients this is also an economically feasible strategy.3
Racial Disparities and Diet
Several unique racial/ethnic disparities exist among hemodialysis patients, such that there is 
a 3.5 and 1.5 fold greater representation of African Americans and Hispanics, respectively, 
compared to non-Hispanic whites.65, 66 For reasons that have remained vastly 
unexplainable, minority dialysis patients exhibit greater survival than non-Hispanic white 
dialysis patients.67 African American dialysis patients are 15 to 20% less likely to die of 
cardiovascular 68 disease than whites especially those who are older than 50 years.69 Recent 
data suggest that significant differences exist between African American and non-Hispanic 
and Hispanic white hemodialysis patients with regards to nutritional status, dietary intake 
and inflammation, and that these differences may contribute to racial survival 
disparities.68, 70 In a 6-year cohort of 799 hemodialysis patients, the dietary intake of 
African Americans was higher in energy (+293 ±119 cal/day) and fat (+18±5 g/day) 
compared to whites.68, 69 Whether or not minorities are less compliant with the dietary 
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restrictions, with subsequent better outcomes is a highly provocative hypothesis that remains 
to be examined in future studies.
Consequences of Dietary Restriction and Future Research Directions
It is not clear whether imposing the traditionally practiced dietary restrictions on dialysis 
patients contributes to improved outcomes. While some dietary restriction appear to be 
justifiable, it is possible, although not yet proven, that overzealous and extensive restrictions 
may lead to poor outcomes including worse survival by virtue of deteriorating the nutritional 
status and patients’ health related quality of life, which is per se related to nutritional 
status.71 There is little doubt that both dietary-nutritional and pharmacologic status of 
dialysis patients have overarching and long-lasting impact on patient survival even after 
successful kidney transplantation.72 As stated above, a case-control study comparing dietary 
patterns of hemodialysis patients versus the general population suggested that dietary 
restriction in dialysis patients, including low potassium and phosphorus, leads to avoidance 
of most fresh fruits and vegetables and a more atherogenic diet with lower vitamin C, fiber, 
and carotenoid.31 In a recent cross-sectional study by Koueiry et al.4 using the “Dialysis 
Food Frequency Questionnaire,"31 97% of hemodialysis patients had lower than the 
recommended dietary fiber intake of 25 g/day or more. The study concluded that most 
dialysis patients did not meet the dietary guidelines for reducing the risk of cardiovascular 
disease.4 Hence, reinforcing dietary restrictions on dialysis patients may contribute to 
atherosclerosis and increased cardiovascular morbidity and mortality.
Some nephrologists have noted that less compliant dialysis patients appear to live longer 
than the more compliant ones, an observation that may have some roots in the 
aforementioned dietary restrictions. Whereas we warn against over-interpretation of 
anecdotal observations, we cannot dismiss the plausible hypothesis that adhering to severe 
dietary restrictions may cause more harm than benefit, no matter how provocative it may 
sound. Many dietitians are under pressure by dialysis companies to achieve lower averaged 
phosphorus and potassium values in their dialysis units, and this may lead to the risky 
practice of hounding patients to eat less in an effort to improve arbitrary numbers. It is time 
to revisit the role of dietitians and nephrologists in the dialysis units and to re-examine 
current practices,1 so that their approach to dietary counseling of dialysis patients may be 
consistent with most recent data such as those by Lynch et al.15 and Shinaberger et al.,14 
which suggest that mere dietary restrictions may be detrimental.
Given the significant knowledge gap discussed above, there is a pressing need for high 
impact research with immediate clinical applicability in the nutritional management of 
dialysis patients. Several relevant questions for future research in this area are the following: 
What are the real impact of restricting dietary potassium, phosphorus, calcium and salt on 
clinical outcomes? What is the best dietary protein range upon transition to dialysis therapy? 
Should the recommended “low” protein diet for advanced CKD prior to ESRD be continued 
for less frequent and incremental hemodialysis regimen including those who receive only 
once or twice weekly hemodialysis therapy73–77 as compared to thrice-weekly or more 
frequent hemodialysis? What types of high biological value proteins including plants vs. 
animal based foods can be recommended as better sources of low phosphorous diet? 
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Additional research on the potential of a more liberalized dietary approach on patient-
centered outcomes would be relevant as well. Overall the benefits and harms of the decade-
long practiced dietary restrictions are widely unknown and need urgent research.
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Figure 1. 
Frequency of different ranges of protein intake estimated by nPCR (nPNA) in 53,933 
hemodialysis patients (adapted from reference 8)8
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Figure 2. 
Associations between dietary protein intake, estimated by nPCR (nPNA) and survival in 
53,933 hemodialysis patients (adapted from reference 8)
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Figure 3. 
Correlation between dietary protein and phosphorus content; a recommended protein intake 
of 1.2 g/kg/day in a 70 kg chronic dialysis patient is equivalent to 85 g/day of protein which 
exceeds the 800 mg/day phosphorus restriction as shown by the black arrows (adapted from 
reference 11)
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Figure 4. 
Association of dietary phosphorus to protein ratio and mortality in hemodialysis patients 
(adapted from reference 19)
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Figure 5. 
Correlation between higher dietary protein intake and higher serum potassium level in 
hemodialysis patients (adapted from reference 27)
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Table 1
Dietary recommendations and restriction in dialysis patients and their implications.
Recommended range Evidence Observations
Dietary protein recommendations 1.2–1.4 g/kg/day Epidemiologic studies 
show greatest survival 
with 1.2–1.4 g/kg/
day.
Most dialysis patients eat <1.0 g/kg/day.
Dietary phosphorus restrictions <800 mg/day Mostly based on 
epidemiologic 
association between 
serum phosphorus 
and mortality.
Adhering to low phosphorus diet may result 
in inadequate protein intake.
Dietary potassium (K) restrictions <3 g/day Very recent data 
suggest an association 
between higher K 
load and death.
Most K rich foods are heart-healthy.
Dietary salt and fluid restrictions <2.5 g/day Salt data are mostly 
opinion based.There 
is more recent data on 
adverse outcomes 
from fluid retention.
Less fluid intake may be difficult to adhere 
to if patients are to eat larger amounts of 
protein and calorie.
Dietary carbohydrate and glycemic 
restrictions
Mostly for diabetic dialysis 
patients
Higher A1c >9% may 
be associated with 
higher death risk.
May aggravate burnt-out diabetes leading to 
poor outcomes, especially if A1c<6%.
Dietary lipid restrictions e.g. DASH diet Recent data show 
benefit of Omega-3 
and unsaturated fatty 
acids.
Dietary fat restriction may aggravate calorie 
malnutrition.
Dietary vitamins and trace 
elements
Different data Mixed data regarding 
vitamin D, and 
inadequate data for 
most others.
Some old data suggest certain vitamins such 
as A should be given with restriction.
Dietary calcium restrictions <1200 mg/day Data are mostly based 
on association 
between serum 
calcium and 
mortality.
Hypocalcemia may be aggravated, 
especially with calcimimetics.
Meals restrictions during 
hemodialysis treatment
Meals during hemodialysis Anecdotal case 
reports regarding 
aspiration during 
hemodialysis while 
eating.
Hemodialysis induced hypoglycemia.
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